These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 16005943

  • 1. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I.
    Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
    [Abstract] [Full Text] [Related]

  • 2. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H, Nagatomo A, Kunitoh H, Kunikane H, Watanabe K.
    Cancer Chemother Pharmacol; 1998 Nov; 42(4):307-12. PubMed ID: 9744776
    [Abstract] [Full Text] [Related]

  • 3. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C, de Jonge ME, Huitema AD, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Cancer Res; 2006 Nov 01; 12(21):6502-8. PubMed ID: 17085665
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML, Hsieh T, Hamata L, Levin A, Swenerton K, Djurdjev O, Vu T, Hu F, Conklin J, Malfair Taylor SC.
    Gynecol Oncol; 2006 Dec 01; 103(3):1063-9. PubMed ID: 16875719
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.
    Marx GM, Blake GM, Galani E, Steer CB, Harper SE, Adamson KL, Bailey DL, Harper PG.
    Ann Oncol; 2004 Feb 01; 15(2):291-5. PubMed ID: 14760124
    [Abstract] [Full Text] [Related]

  • 6. Estimation of glomerular filtration rate in cancer patients.
    Wright JG, Boddy AV, Highley M, Fenwick J, McGill A, Calvert AH.
    Br J Cancer; 2001 Feb 01; 84(4):452-9. PubMed ID: 11207037
    [Abstract] [Full Text] [Related]

  • 7. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A, McCune JS, Faucette S, Gillenwater HH, Kowalski RJ, Socinski MA, Lindley C.
    Cancer Chemother Pharmacol; 2001 May 01; 47(5):373-9. PubMed ID: 11391850
    [Abstract] [Full Text] [Related]

  • 8. Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.
    Huitema AD, Mathôt RA, Tibben MM, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Pharmacol Ther; 2000 Jun 01; 67(6):621-30. PubMed ID: 10872644
    [Abstract] [Full Text] [Related]

  • 9. A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma.
    Quinton A, Lewis P, Ali P, Morgan C, Bertelli G.
    Med Oncol; 2013 Jun 01; 30(3):661. PubMed ID: 23864250
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
    Holweger K, Lipp HP, Beijnen JH, Bokemeyer C, Hartmann JT.
    Cancer Chemother Pharmacol; 2011 Sep 01; 68(3):693-701. PubMed ID: 21136060
    [Abstract] [Full Text] [Related]

  • 11. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST, Gillen G, Morrison P, Forte C, Macpherson IR, White JD, Mark PB.
    Eur J Cancer; 2014 Mar 01; 50(5):944-52. PubMed ID: 24445148
    [Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
    Herrington JD, Tran HT, Riggs MW.
    Cancer Chemother Pharmacol; 2006 Jan 01; 57(2):241-7. PubMed ID: 16133538
    [Abstract] [Full Text] [Related]

  • 13. Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level.
    Ando M, Minami H, Ando Y, Saka H, Sakai S, Yamamoto M, Sasaki Y, Shimokata K, Hasegawa Y.
    Clin Cancer Res; 2000 Dec 01; 6(12):4733-8. PubMed ID: 11156227
    [Abstract] [Full Text] [Related]

  • 14. A modified Cockcroft-Gault formula taking into account the body surface area gives a more accurate estimation of the glomerular filtration rate.
    Rostoker G, Andrivet P, Pham I, Griuncelli M, Adnot S.
    J Nephrol; 2007 Dec 01; 20(5):576-85. PubMed ID: 17918143
    [Abstract] [Full Text] [Related]

  • 15. A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT.
    Hahn T, Yao S, Dunford LM, Thomas J, Lohr J, Arora P, Battiwalla M, Smiley SL, McCarthy PL.
    Biol Blood Marrow Transplant; 2009 May 01; 15(5):574-9. PubMed ID: 19361749
    [Abstract] [Full Text] [Related]

  • 16. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ, Poole SG, Rischin D, Webster LK.
    Eur J Cancer; 2002 Jan 01; 38(1):44-51. PubMed ID: 11750838
    [Abstract] [Full Text] [Related]

  • 17. Calculation of creatinine clearance from plasma creatinine.
    McLigeyo SO.
    East Afr Med J; 1993 Jan 01; 70(1):3-5. PubMed ID: 8513724
    [Abstract] [Full Text] [Related]

  • 18. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K, Harmoinen AP, Lehtimäki TJ, Korpela MM, Mustonen JT, Saha HH.
    Nephron Clin Pract; 2008 Jan 01; 108(4):c284-90. PubMed ID: 18434750
    [Abstract] [Full Text] [Related]

  • 19. The correlation of renal allograft weight to metabolic index ratios and glomerular filtration rate among living-unrelated kidney transplant patients: a cross-sectional study.
    Amante AJ, Piñon-Barretto SC.
    Transplant Proc; 2008 Sep 01; 40(7):2313-8. PubMed ID: 18790222
    [Abstract] [Full Text] [Related]

  • 20. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
    Ekhart C, Rodenhuis S, Schellens JH, Beijnen JH, Huitema AD.
    Cancer Chemother Pharmacol; 2009 Jun 01; 64(1):115-22. PubMed ID: 18989671
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.